PUBLISHER: Lucintel | PRODUCT CODE: 1386285
PUBLISHER: Lucintel | PRODUCT CODE: 1386285
Influenza Vaccine Trends and Forecast
The future of the global influenza vaccine market looks promising with opportunities in the hospital & retail pharmacy and government supplier channels. The global influenza vaccine market is expected to reach an estimated $11.22 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are rising demand for more effective and less invasive influenza vaccines, growing awareness of the benefits of influenza vaccines, and supportive government initiatives to promote influenza vaccination.
A more than 150-page report is developed to help in your business decisions.
Influenza Vaccine by Segment
The study includes a forecast for the global influenza vaccine by vaccine type, distribution channel, and region.
Influenza Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:
Influenza Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
Influenza Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Influenza Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies influenza vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the influenza vaccine companies profiled in this report include-
Influenza Vaccine Market Insights
Lucintel forecasts that inactivated is expected to witness higher growth over the forecast period due to growing demand for these vaccinations given to its safety and effectiveness.
Within this market, hospital & retail pharmacy is expected to witness highest growth over the forecast period as they are the easiest and most accessible locations to acquire a flu vaccine.
North America is expected to witness highest growth over the forecast period due to high prevalence of influenza, availability of well-established healthcare system, and high preference for vaccination in the region.
Features of the Global Influenza Vaccine Market
Market Size Estimates: Influenza vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Influenza vaccine market size by vaccine type, distribution channel, and region in terms of value ($B).
Regional Analysis: Influenza vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different vaccine types, distribution channels, and regions for the influenza vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the influenza vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the influenza vaccine market size?
Answer: The global influenza vaccine market is expected to reach an estimated $11.22 billion by 2030.
Q.2 What is the growth forecast for influenza vaccine market?
Answer: The global influenza vaccine market is expected to grow with a CAGR of 6.8% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the influenza vaccine market?
Answer: The major drivers for this market are rising demand for more effective and less invasive influenza vaccines, growing awareness of the benefits of influenza vaccines, and supportive government initiatives to promote influenza vaccination.
Q4. What are the major segments for influenza vaccine market?
Answer: The future of the influenza vaccine market looks promising with opportunities in the hospital & retail pharmacy and government supplier channels.
Q5. Who are the key influenza vaccine market companies?
Answer: Some of the key influenza vaccine companies are as follows:
Q6. Which influenza vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that inactivated is expected to witness higher growth over the forecast period due to growing demand for these vaccinations given to its safety and effectiveness.
Q7. In influenza vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of influenza, availability of well-established healthcare system, and high preference for vaccination in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.